What should be the primary target of "treat to target" in psoriatic arthritis?

What should be the primary target of "treat to target" in psoriatic arthritis?

<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Journal of Rheumatology 2018

Ижил төстэй зүйлс

What should be the primary target of ‘treat to target’ in PsA?
-н: Coates, L, зэрэг
Хэвлэсэн: (2018)

Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
-н: Coates, L, зэрэг
Хэвлэсэн: (2022)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
-н: Coates, L, зэрэг
Хэвлэсэн: (2019)

Sustained very low disease activity and remission in psoriatic arthritis patients
-н: Lubrano, E, зэрэг
Хэвлэсэн: (2019)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
-н: Lubrano E, зэрэг
Хэвлэсэн: (2016-10-01)

New approved drugs for psoriatic arthritis
-н: F.M. Perrotta, зэрэг
Хэвлэсэн: (2016-09-01)

Precision medicine in psoriatic arthritis: how should we select targeted therapies?
-н: Al-Mossawi, H, зэрэг
Хэвлэсэн: (2019)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
-н: Ennio Lubrano, зэрэг
Хэвлэсэн: (2019-08-01)

How should we define disease and outcomes in axial psoriatic arthritis?
-н: Coates, LC
Хэвлэсэн: (2021)

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
-н: Ennio Lubrano, зэрэг
Хэвлэсэн: (2023-07-01)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
-н: P.S. Helliwell
Хэвлэсэн: (2011-09-01)

The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.
-н: Coates, L, зэрэг
Хэвлэсэн: (2017)

Does treat to target or achieving remission improve radiographic outcome in psa?
-н: Coates, L, зэрэг
Хэвлэсэн: (2016)

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores
-н: Weinstein, SM, зэрэг
Хэвлэсэн: (2021)

Novel concepts in psoriatic arthritis management: Can we treat to target?
-н: Tucker, L, зэрэг
Хэвлэсэн: (2018)

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
-н: Dures, E, зэрэг
Хэвлэсэн: (2020)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
-н: Ye, W, зэрэг
Хэвлэсэн: (2021)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
-н: Gladman, DD, зэрэг
Хэвлэсэн: (2022)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
-н: Helliwell, PS, зэрэг
Хэвлэсэн: (2023)

Assessment of patient-physician interactions in psoriatic arthritis: national results of the ASSIST Study
-н: Perrotta, FM, зэрэг
Хэвлэсэн: (2024)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
-н: Ye, W, зэрэг
Хэвлэсэн: (2021)

Occult axial involvement in patients with psoriatic arthritis mutilans: a case report
-н: F.M. Perrotta, зэрэг
Хэвлэсэн: (2019-07-01)

Current concepts and unmet needs in psoriatic arthritis
-н: Mahmood, F, зэрэг
Хэвлэсэн: (2017)

Psoriatic arthritis: prospects for the future
-н: Hackett, S, зэрэг
Хэвлэсэн: (2022)

Should methotrexate have any place in the treatment of psoriatic arthritis?
-н: Ye, W, зэрэг
Хэвлэсэн: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
-н: Helliwell, PS, зэрэг
Хэвлэсэн: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
-н: Coates, L, зэрэг
Хэвлэсэн: (2016)

Measuring outcomes in psoriatic arthritis
-н: Ogdie, A, зэрэг
Хэвлэсэн: (2020)

Outcome measures in psoriatic arthritis: where next?
-н: Hackett, S, зэрэг
Хэвлэсэн: (2022)

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
-н: Ennio Lubrano, зэрэг
Хэвлэсэн: (2022-12-01)

Psoriatic arthritis: lessons from imaging studies and implications for therapy
-н: Mathew, A, зэрэг
Хэвлэсэн: (2016)

Assessing disease activity in psoriatic arthritis: a literature review
-н: Tucker, L, зэрэг
Хэвлэсэн: (2018)

Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
-н: Mease, PJ, зэрэг
Хэвлэсэн: (2020)

Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
-н: Helliwell, P, зэрэг
Хэвлэсэн: (2019)

Cost-effectiveness of tight control of inflammation in early psoriatic arthritis: economic analysis of a multicenter randomized controlled trial
-н: O'Dwyer, J, зэрэг
Хэвлэсэн: (2018)

Remission in psoriatic arthritis—where are we now?
-н: Coates, L, зэрэг
Хэвлэсэн: (2017)

Identification of psoriatic arthritis in patients with psoriasis
-н: Coates, LC, зэрэг
Хэвлэсэн: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
-н: Soriano, ER, зэрэг
Хэвлэсэн: (2023)

Psoriatic arthritis: imaging techniques
-н: E. Lubrano, зэрэг
Хэвлэсэн: (2012-06-01)

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
-н: Coates, L, зэрэг
Хэвлэсэн: (2018)